- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $55.8M
- Price
- $6.27
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.32%
- Volume
- 150
About
No description available.
Quick stats
Shares outstanding8.9M
Computed float2.3M
Float / shares25.8%
AI Summary
AI-generated3mo agostandard
Adaptin Bio Shares (Ticker: APTN) Commence Trading on the OTCQB
CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the brain and other difficult-to-reach tissues, today announced that its common stock has commenced trading on the OTCQB® Venture Market under the ticker symbol APTN. OTCQB trading is expected to provide greater access to U.S. investors, improve liquidity, and enhance visibility within the investment community.